Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Zosano Pharma Corp (ZSAN) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/07/2022 4 Matthews Christine (CFO) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 82 shares @ $0.71, valued at $58.2
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2022 4 Matthews Christine (CFO) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 8,116 shares @ $0.2101, valued at $1.7k
04/01/2022 4 KELLERMAN DONALD J (VP, Clinical Dev & Med Affairs) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 4,006 shares @ $0.2101, valued at $841.7
04/01/2022 4 Lo Steven (CEO) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 23,633 shares @ $0.2101, valued at $5k
12/09/2021 4 Yang Elaine (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 90,000 options to buy @ $0.558, valued at $50.2k
11/24/2021 4 GREATHOUSE KENNETH (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 10,000 shares @ $0.6018, valued at $6k
10/19/2021 4 KELLERMAN DONALD J (VP, Clinical Dev & Med Affairs) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $0.6342, valued at $12.7k
10/19/2021 4 Matthews Christine (CFO) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 56,250 shares @ $0
Granted 112,500 options to buy @ $0.6342, valued at $71.3k
10/19/2021 4 Lo Steven (CEO) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 118,750 shares @ $0
Granted 237,500 options to buy @ $0.6342, valued at $150.6k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 GREATHOUSE KENNETH (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 15,000 shares @ $0
Granted 30,000 options to buy @ $0.9318, valued at $28k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Lewis Hayley (See Remarks) has filed a Form 4 on Zosano Pharma Corp
Txns: Sold 1,709 shares @ $0.805, valued at $1.4k
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 McGee Kathy M. (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 90,000 options to buy @ $0.73, valued at $65.7k
05/18/2021 4 GREATHOUSE KENNETH (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 21,000 shares @ $0.7291, valued at $15.3k
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 4 Lewis Hayley (See Remarks) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 32,500 shares @ $0
Granted 65,000 options to buy @ $1.2, valued at $78k
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 GREATHOUSE KENNETH (Director) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 7,500 shares @ $0
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Lewis Hayley (See Remarks) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 18,750 shares @ $0
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy